John R. Moore - General Counsel at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
EWTX on Nasdaq
All Insider Reports
All Insider Reports

John R. Moore - trading volume in the past year for Edgewise Therapeutics, Inc.

Holdings reported by John R. Moore for Edgewise Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 26,875 $437,294 $18.91 12 Aug 2025 Direct Common Stock
Common Stock 10,214 $136,789 $13.39 12 Aug 2025 Direct
Stock Option (Right to Buy) 161,250 12 Aug 2025 Direct Common Stock

Transactions reported by John R. Moore for Edgewise Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.